お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、APIの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にAPI市場を分類しています。
本レポートでは世界のAPI市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Teva、Viatris、DSM、Aurobindo Pharma、Aspen、Novartis、BASF、Pfizer、Huahai Pharmaceutical、Hisun Pharmaceutical、Sun Pharmaceutical Industries、Zhejiang Medicine、Dr. Reddy’s Laboratories、Zhejiang NHU、Apeloa Pharmaceutical、NCPC、United Laboratories、Shandong Xinhua Pharmaceutical、CSPC、Harbin Pharmaceutical、LKPC

レポートはAPIの主要生産者を調査し、主要地域や国の消費状況も提供します。APIの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Synthetic APIs
    Biotech APIs

用途別の市場セグメント：
    Tablet
    Injection
    Capsule
    Others

本レポートの詳細内容
本レポートは、世界のAPI市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてAPI市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のAPI生産量、成長率、市場シェアを調査している。

二. 消費面では、APIの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのAPI売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のAPI市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本APIのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：APIのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： APIの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるAPIの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章APIメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：APIの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：APIの主要メーカーの概要を提供し、製品の説明と仕様、APIの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：APIの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The global Active Pharmaceutical Ingredients (API) market is projected to grow from US$ 181840 million in 2024 to US$ 269850 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
The Active Pharmaceutical Ingredients (API) market is driven by several key factors, with one of the main drivers being the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. As the global population ages, there is a growing demand for medications to treat these long-term conditions, which in turn drives the demand for high-quality APIs used in drug manufacturing. Furthermore, advancements in biotechnology and the growing trend toward personalized medicine have expanded the range of APIs being developed, particularly in complex biologics.Another major driver is the rise in generic drug production. With the patent expirations of many blockbuster drugs, generic manufacturers are capitalizing on opportunities to produce cheaper alternatives, which require cost-effective, high-quality APIs. Regulatory support for generics, particularly in developing regions, has further spurred the growth of the API market, as governments push for more affordable healthcare options.Despite these growth drivers, the API market faces several challenges. One of the most significant is the increasing regulatory scrutiny and the need for compliance with stringent quality standards, especially for APIs manufactured in developing countries. Additionally, the market is highly competitive, and manufacturers must deal with fluctuating raw material costs, supply chain disruptions, and price pressures. This combination of regulatory and economic hurdles requires significant investment in infrastructure and innovation to maintain competitiveness in the API landscape.
In terms of production side, this report researches the Active Pharmaceutical Ingredients (API) production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Active Pharmaceutical Ingredients (API) by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Active Pharmaceutical Ingredients (API), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Active Pharmaceutical Ingredients (API), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Active Pharmaceutical Ingredients (API), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Active Pharmaceutical Ingredients (API) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Active Pharmaceutical Ingredients (API) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Active Pharmaceutical Ingredients (API) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Viatris, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer, Huahai Pharmaceutical, Hisun Pharmaceutical, etc.

Market Segmentation
By Company
    Teva
    Viatris
    DSM
    Aurobindo Pharma
    Aspen
    Novartis
    BASF
    Pfizer
    Huahai Pharmaceutical
    Hisun Pharmaceutical
    Sun Pharmaceutical Industries
    Zhejiang Medicine
    Dr. Reddy’s Laboratories
    Zhejiang NHU
    Apeloa Pharmaceutical
    NCPC
    United Laboratories
    Shandong Xinhua Pharmaceutical
    CSPC
    Harbin Pharmaceutical
    LKPC

Segment by Type
    Synthetic APIs
    Biotech APIs

Segment by Application
    Tablet
    Injection
    Capsule
    Others

Production by Region
    North America
    Europe
    China
    Japan
    India

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Active Pharmaceutical Ingredients (API) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Active Pharmaceutical Ingredients (API) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Active Pharmaceutical Ingredients (API) sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
 Table 1. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Key Manufacturers of Synthetic APIs
 Table 3. Key Manufacturers of Biotech APIs
 Table 4. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 5. Global Active Pharmaceutical Ingredients (API) Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
 Table 6. Global Active Pharmaceutical Ingredients (API) Production by Region (2019-2024) & (Tons)
 Table 7. Global Active Pharmaceutical Ingredients (API) Production by Region (2025-2030) & (Tons)
 Table 8. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2024)
 Table 9. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2025-2030)
 Table 10. Global Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 11. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2019-2024) & (US$ Million)
 Table 12. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2025-2030) & (US$ Million)
 Table 13. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2019-2024)
 Table 14. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2025-2030)
 Table 15. Global Active Pharmaceutical Ingredients (API) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
 Table 16. Global Active Pharmaceutical Ingredients (API) Sales by Region (2019-2024) & (Tons)
 Table 17. Global Active Pharmaceutical Ingredients (API) Sales by Region (2025-2030) & (Tons)
 Table 18. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2019-2024)
 Table 19. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2025-2030)
 Table 20. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2019-2024) & (Tons)
 Table 21. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2019-2024)
 Table 22. Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 23. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2019-2024)
 Table 24. Active Pharmaceutical Ingredients (API) Price by Manufacturers (2019-2024) & (USD/Ton)
 Table 25. Global Key Players of Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023
 Table 26. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 27. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2023)
 Table 28. Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Manufacturing Base Distribution and Headquarters
 Table 29. Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Product Offered and Application
 Table 30. Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Date of Enter into This Industry
 Table 31. Mergers & Acquisitions, Expansion Plans
 Table 32. Global Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons)
 Table 33. Global Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons)
 Table 34. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2019-2024)
 Table 35. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2025-2030)
 Table 36. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million)
 Table 37. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million)
 Table 38. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2019-2024)
 Table 39. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2025-2030)
 Table 40. Active Pharmaceutical Ingredients (API) Price by Type (2019-2024) & (USD/Ton)
 Table 41. Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2025-2030) & (USD/Ton)
 Table 42. Global Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons)
 Table 43. Global Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons)
 Table 44. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2019-2024)
 Table 45. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2025-2030)
 Table 46. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million)
 Table 47. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million)
 Table 48. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2019-2024)
 Table 49. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2025-2030)
 Table 50. Active Pharmaceutical Ingredients (API) Price by Application (2019-2024) & (USD/Ton)
 Table 51. Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2025-2030) & (USD/Ton)
 Table 52. US & Canada Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons)
 Table 53. US & Canada Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons)
 Table 54. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million)
 Table 55. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million)
 Table 56. US & Canada Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons)
 Table 57. US & Canada Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons)
 Table 58. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million)
 Table 59. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million)
 Table 60. US & Canada Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 61. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2024) & (US$ Million)
 Table 62. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Country (2025-2030) & (US$ Million)
 Table 63. US & Canada Active Pharmaceutical Ingredients (API) Sales by Country (2019-2024) & (Tons)
 Table 64. US & Canada Active Pharmaceutical Ingredients (API) Sales by Country (2025-2030) & (Tons)
 Table 65. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons)
 Table 66. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons)
 Table 67. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million)
 Table 68. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million)
 Table 69. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons)
 Table 70. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons)
 Table 71. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million)
 Table 72. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million)
 Table 73. Europe Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 74. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2019-2024) & (Tons)
 Table 75. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2025-2030) & (Tons)
 Table 76. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2024) & (US$ Million)
 Table 77. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2025-2030) & (US$ Million)
 Table 78. China Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons)
 Table 79. China Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons)
 Table 80. China Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million)
 Table 81. China Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million)
 Table 82. China Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons)
 Table 83. China Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons)
 Table 84. China Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million)
 Table 85. China Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million)
 Table 86. Asia Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons)
 Table 87. Asia Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons)
 Table 88. Asia Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million)
 Table 89. Asia Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million)
 Table 90. Asia Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons)
 Table 91. Asia Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons)
 Table 92. Asia Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million)
 Table 93. Asia Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million)
 Table 94. Asia Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 95. Asia Active Pharmaceutical Ingredients (API) Revenue by Region (2019-2024) & (US$ Million)
 Table 96. Asia Active Pharmaceutical Ingredients (API) Revenue by Region (2025-2030) & (US$ Million)
 Table 97. Asia Active Pharmaceutical Ingredients (API) Sales by Region (2019-2024) & (Tons)
 Table 98. Asia Active Pharmaceutical Ingredients (API) Sales by Region (2025-2030) & (Tons)
 Table 99. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons)
 Table 100. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons)
 Table 101. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million)
 Table 102. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million)
 Table 103. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons)
 Table 104. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons)
 Table 105. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million)
 Table 107. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 108. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2024) & (US$ Million)
 Table 109. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2025-2030) & (US$ Million)
 Table 110. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2019-2024) & (Tons)
 Table 111. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2025-2030) & (Tons)
 Table 112. Teva Corporation Information
 Table 113. Teva Description and Major Businesses
 Table 114. Teva Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 115. Teva Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. Teva Recent Developments
 Table 117. Viatris Corporation Information
 Table 118. Viatris Description and Major Businesses
 Table 119. Viatris Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 120. Viatris Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. Viatris Recent Developments
 Table 122. DSM Corporation Information
 Table 123. DSM Description and Major Businesses
 Table 124. DSM Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 125. DSM Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. DSM Recent Developments
 Table 127. Aurobindo Pharma Corporation Information
 Table 128. Aurobindo Pharma Description and Major Businesses
 Table 129. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 130. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. Aurobindo Pharma Recent Developments
 Table 132. Aspen Corporation Information
 Table 133. Aspen Description and Major Businesses
 Table 134. Aspen Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 135. Aspen Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. Aspen Recent Developments
 Table 137. Novartis Corporation Information
 Table 138. Novartis Description and Major Businesses
 Table 139. Novartis Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 140. Novartis Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. Novartis Recent Developments
 Table 142. BASF Corporation Information
 Table 143. BASF Description and Major Businesses
 Table 144. BASF Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 145. BASF Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. BASF Recent Developments
 Table 147. Pfizer Corporation Information
 Table 148. Pfizer Description and Major Businesses
 Table 149. Pfizer Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 150. Pfizer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. Pfizer Recent Developments
 Table 152. Huahai Pharmaceutical Corporation Information
 Table 153. Huahai Pharmaceutical Description and Major Businesses
 Table 154. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 155. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Huahai Pharmaceutical Recent Developments
 Table 157. Hisun Pharmaceutical Corporation Information
 Table 158. Hisun Pharmaceutical Description and Major Businesses
 Table 159. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 160. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 161. Hisun Pharmaceutical Recent Developments
 Table 162. Sun Pharmaceutical Industries Corporation Information
 Table 163. Sun Pharmaceutical Industries Description and Major Businesses
 Table 164. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 165. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 166. Sun Pharmaceutical Industries Recent Developments
 Table 167. Zhejiang Medicine Corporation Information
 Table 168. Zhejiang Medicine Description and Major Businesses
 Table 169. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 170. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 171. Zhejiang Medicine Recent Developments
 Table 172. Dr. Reddy’s Laboratories Corporation Information
 Table 173. Dr. Reddy’s Laboratories Description and Major Businesses
 Table 174. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 175. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 176. Dr. Reddy’s Laboratories Recent Developments
 Table 177. Zhejiang NHU Corporation Information
 Table 178. Zhejiang NHU Description and Major Businesses
 Table 179. Zhejiang NHU Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 180. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 181. Zhejiang NHU Recent Developments
 Table 182. Apeloa Pharmaceutical Corporation Information
 Table 183. Apeloa Pharmaceutical Description and Major Businesses
 Table 184. Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 185. Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 186. Apeloa Pharmaceutical Recent Developments
 Table 187. NCPC Corporation Information
 Table 188. NCPC Description and Major Businesses
 Table 189. NCPC Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 190. NCPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 191. NCPC Recent Developments
 Table 192. United Laboratories Corporation Information
 Table 193. United Laboratories Description and Major Businesses
 Table 194. United Laboratories Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 195. United Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 196. United Laboratories Recent Developments
 Table 197. Shandong Xinhua Pharmaceutical Corporation Information
 Table 198. Shandong Xinhua Pharmaceutical Description and Major Businesses
 Table 199. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 200. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 201. Shandong Xinhua Pharmaceutical Recent Developments
 Table 202. CSPC Corporation Information
 Table 203. CSPC Description and Major Businesses
 Table 204. CSPC Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 205. CSPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 206. CSPC Recent Developments
 Table 207. Harbin Pharmaceutical Corporation Information
 Table 208. Harbin Pharmaceutical Description and Major Businesses
 Table 209. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 210. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 211. Harbin Pharmaceutical Recent Developments
 Table 212. LKPC Corporation Information
 Table 213. LKPC Description and Major Businesses
 Table 214. LKPC Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
 Table 215. LKPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 216. LKPC Recent Developments
 Table 217. Key Raw Materials Lists
 Table 218. Raw Materials Key Suppliers Lists
 Table 219. Active Pharmaceutical Ingredients (API) Distributors List
 Table 220. Active Pharmaceutical Ingredients (API) Customers List
 Table 221. Active Pharmaceutical Ingredients (API) Market Trends
 Table 222. Active Pharmaceutical Ingredients (API) Market Drivers
 Table 223. Active Pharmaceutical Ingredients (API) Market Challenges
 Table 224. Active Pharmaceutical Ingredients (API) Market Restraints
 Table 225. Research Programs/Design for This Report
 Table 226. Key Data Information from Secondary Sources
 Table 227. Key Data Information from Primary Sources


List of Figures
 Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
 Figure 2. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Active Pharmaceutical Ingredients (API) Market Share by Type: 2023 & 2030
 Figure 4. Synthetic APIs Product Picture
 Figure 5. Biotech APIs Product Picture
 Figure 6. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 7. Global Active Pharmaceutical Ingredients (API) Market Share by Application in 2024 & 2030
 Figure 8. Tablet
 Figure 9. Injection
 Figure 10. Capsule
 Figure 11. Others
 Figure 12. Active Pharmaceutical Ingredients (API) Report Years Considered
 Figure 13. Global Active Pharmaceutical Ingredients (API) Capacity, Production and Utilization (2019-2030) & (Tons)
 Figure 14. Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030 (Tons)
 Figure 15. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region in Percentage: 2023 Versus 2030
 Figure 16. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2030)
 Figure 17. Active Pharmaceutical Ingredients (API) Production Growth Rate in North America (2019-2030) & (Tons)
 Figure 18. Active Pharmaceutical Ingredients (API) Production Growth Rate in Europe (2019-2030) & (Tons)
 Figure 19. Active Pharmaceutical Ingredients (API) Production Growth Rate in China (2019-2030) & (Tons)
 Figure 20. Active Pharmaceutical Ingredients (API) Production Growth Rate in Japan (2019-2030) & (Tons)
 Figure 21. Active Pharmaceutical Ingredients (API) Production Growth Rate in India (2019-2030) & (Tons)
 Figure 22. Global Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 23. Global Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 24. Global Active Pharmaceutical Ingredients (API) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 25. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 26. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2019-2030)
 Figure 27. Global Active Pharmaceutical Ingredients (API) Sales (2019-2030) & (Tons)
 Figure 28. Global Active Pharmaceutical Ingredients (API) Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
 Figure 29. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2019-2030)
 Figure 30. US & Canada Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons)
 Figure 31. US & Canada Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Europe Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons)
 Figure 33. Europe Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million)
 Figure 34. China Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons)
 Figure 35. China Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million)
 Figure 36. Asia (excluding China) Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons)
 Figure 37. Asia (excluding China) Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million)
 Figure 38. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons)
 Figure 39. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million)
 Figure 40. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2023)
 Figure 41. The Active Pharmaceutical Ingredients (API) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 42. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2023)
 Figure 43. The Top 5 and 10 Largest Manufacturers of Active Pharmaceutical Ingredients (API) in the World: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2023
 Figure 44. Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 45. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
 Figure 46. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
 Figure 47. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
 Figure 48. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
 Figure 49. US & Canada Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
 Figure 50. US & Canada Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
 Figure 51. US & Canada Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
 Figure 52. US & Canada Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
 Figure 53. US & Canada Active Pharmaceutical Ingredients (API) Revenue Share by Country (2019-2030)
 Figure 54. US & Canada Active Pharmaceutical Ingredients (API) Sales Share by Country (2019-2030)
 Figure 55. US Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 56. Canada Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 57. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
 Figure 58. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
 Figure 59. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
 Figure 60. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
 Figure 61. Europe Active Pharmaceutical Ingredients (API) Sales Share by Country (2019-2030)
 Figure 62. Europe Active Pharmaceutical Ingredients (API) Revenue Share by Country (2019-2030)
 Figure 63. Germany Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 64. France Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 65. U.K. Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 66. Italy Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 67. Russia Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 68. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
 Figure 69. China Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
 Figure 70. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
 Figure 71. China Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
 Figure 72. Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
 Figure 73. Asia Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
 Figure 74. Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
 Figure 75. Asia Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
 Figure 76. Asia Active Pharmaceutical Ingredients (API) Revenue Share by Region (2019-2030)
 Figure 77. Asia Active Pharmaceutical Ingredients (API) Sales Share by Region (2019-2030)
 Figure 78. Japan Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 79. South Korea Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 80. China Taiwan Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 81. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 82. India Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 83. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
 Figure 84. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
 Figure 85. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
 Figure 86. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
 Figure 87. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Share by Country (2019-2030)
 Figure 88. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales Share by Country (2019-2030)
 Figure 89. Brazil Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 90. Mexico Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 91. Turkey Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 92. Israel Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 93. GCC Countries Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million)
 Figure 94. Active Pharmaceutical Ingredients (API) Value Chain
 Figure 95. Active Pharmaceutical Ingredients (API) Production Process
 Figure 96. Channels of Distribution (Direct Vs Distribution)
 Figure 97. Bottom-up and Top-down Approaches for This Report
 Figure 98. Data Triangulation
 Figure 99. Key Executives Interviewed